153 related articles for article (PubMed ID: 18034899)
1. Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.
Wilson R; Bate C; Boshuizen R; Williams A; Brewer J
BMC Neurosci; 2007 Nov; 8():99. PubMed ID: 18034899
[TBL] [Abstract][Full Text] [Related]
2. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
Bate C; Salmona M; Diomede L; Williams A
J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
[TBL] [Abstract][Full Text] [Related]
3. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42).
Bate C; Williams A
Neuropharmacology; 2007 Aug; 53(2):222-31. PubMed ID: 17583757
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phospholipase A2 increased the removal of the prion derived peptide PrP82-146 from cultured neurons.
Bate C; Ingham V; Williams A
Neuropharmacology; 2011; 60(2-3):365-72. PubMed ID: 20934441
[TBL] [Abstract][Full Text] [Related]
5. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.
Goold R; McKinnon C; Rabbanian S; Collinge J; Schiavo G; Tabrizi SJ
J Cell Sci; 2013 Aug; 126(Pt 16):3552-62. PubMed ID: 23813960
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol depletion by methyl-beta-cyclodextrin blocks cholera toxin transport from endosomes to the Golgi apparatus in hippocampal neurons.
Shogomori H; Futerman AH
J Neurochem; 2001 Sep; 78(5):991-9. PubMed ID: 11553673
[TBL] [Abstract][Full Text] [Related]
7. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42.
Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A
Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880
[TBL] [Abstract][Full Text] [Related]
9. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes.
Vetrivel KS; Cheng H; Lin W; Sakurai T; Li T; Nukina N; Wong PC; Xu H; Thinakaran G
J Biol Chem; 2004 Oct; 279(43):44945-54. PubMed ID: 15322084
[TBL] [Abstract][Full Text] [Related]
10. Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro.
Bate C; Rutherford S; Gravenor M; Reid S; Williams A
Neuroreport; 2002 Oct; 13(15):1933-8. PubMed ID: 12395095
[TBL] [Abstract][Full Text] [Related]
11. Trafficking of cholera toxin-ganglioside GM1 complex into Golgi and induction of toxicity depend on actin cytoskeleton.
Badizadegan K; Wheeler HE; Fujinaga Y; Lencer WI
Am J Physiol Cell Physiol; 2004 Nov; 287(5):C1453-62. PubMed ID: 15294854
[TBL] [Abstract][Full Text] [Related]
12. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
West E; Osborne C; Bate C
J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
[TBL] [Abstract][Full Text] [Related]
13. The prion protein requires cholesterol for cell surface localization.
Gilch S; Kehler C; Schätzl HM
Mol Cell Neurosci; 2006 Feb; 31(2):346-53. PubMed ID: 16278084
[TBL] [Abstract][Full Text] [Related]
14. Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts.
Russelakis-Carneiro M; Hetz C; Maundrell K; Soto C
Am J Pathol; 2004 Nov; 165(5):1839-48. PubMed ID: 15509552
[TBL] [Abstract][Full Text] [Related]
15. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.
Massignan T; Biasini E; Lauranzano E; Veglianese P; Pignataro M; Fioriti L; Harris DA; Salmona M; Chiesa R; Bonetto V
Mol Cell Proteomics; 2010 Apr; 9(4):611-22. PubMed ID: 19996123
[TBL] [Abstract][Full Text] [Related]
16. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
Williams RS; Bate C
Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
[TBL] [Abstract][Full Text] [Related]
17. A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides.
Fischer R; Köhler K; Fotin-Mleczek M; Brock R
J Biol Chem; 2004 Mar; 279(13):12625-35. PubMed ID: 14707144
[TBL] [Abstract][Full Text] [Related]
18. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
19. Disturbed vesicular trafficking of membrane proteins in prion disease.
Uchiyama K; Miyata H; Sakaguchi S
Prion; 2013; 7(6):447-51. PubMed ID: 24335150
[TBL] [Abstract][Full Text] [Related]
20. Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi.
Brown LR; Harris DA
J Neurochem; 2003 Oct; 87(2):353-63. PubMed ID: 14511113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
